Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henning Schmidt

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Oncology Letters|October 8, 2014
Rapid response to systemic bevacizumab therapy in recurrent respiratory papillomatosisMichael Mohr, Christoph Schliemann, Christoph Biermann, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 19, 2014
Prognostic impact of Bcl-2 depends on tumor histology and expression of MALAT-1 lncRNA in non-small-cell lung cancerLars Henning Schmidt, Dennis Görlich, Tilmann Spieker, et al.
Lung Cancer (Amsterdam, Netherlands)|November 8, 2017
CD13 as target for tissue factor induced tumor vascular infarction in small cell lung cancerLars Henning Schmidt, Janine Stucke-Ring, Caroline Brand, et al.
Plos One|August 28, 2015
PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined SubgroupsLars Henning Schmidt, Andreas Kümmel, Dennis Görlich, et al.
Plos One|June 13, 2017
Potential therapeutic impact of CD13 expression in non-small cell lung cancerLars Henning Schmidt, Caroline Brand, Janine Stucke-Ring, et al.
Plos One|August 10, 2017
Correction: Potential therapeutic impact of CD13 expression in non-small cell lung cancerLars Henning Schmidt, Caroline Brand, Janine Stucke-Ring, et al.
European Journal of Haematology|March 29, 2017
Progressive histoplasmosis with hemophagocytic lymphohistiocytosis and epithelioid cell granulomatosis: A case report and review of the literatureArik Bernard Schulze, Britta Heptner, Torsten Kessler, et al.
Plos One|October 28, 2017
Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancerLars Henning Schmidt, Birthe Heitkötter, Arik B Schulze, et al.
Translational Oncology|August 21, 2018
Aminopeptidase N (CD13): Expression, Prognostic Impact, and Use as Therapeutic Target for Tissue Factor Induced Tumor Vascular Infarction in Soft Tissue SarcomaTorsten Kessler, Ariane Baumeier, Caroline Brand, et al.
Oncotarget|October 15, 2016
Combinatorial effects of doxorubicin and retargeted tissue factor by intratumoral entrapment of doxorubicin and proapoptotic increase of tumor vascular infarctionJanine Stucke-Ring, Julian Ronnacker, Caroline Brand, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Oncology Letters|October 8, 2014
Rapid response to systemic bevacizumab therapy in recurrent respiratory papillomatosisMichael Mohr, Christoph Schliemann, Christoph Biermann, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 19, 2014
Prognostic impact of Bcl-2 depends on tumor histology and expression of MALAT-1 lncRNA in non-small-cell lung cancerLars Henning Schmidt, Dennis Görlich, Tilmann Spieker, et al.
Lung Cancer (Amsterdam, Netherlands)|November 8, 2017
CD13 as target for tissue factor induced tumor vascular infarction in small cell lung cancerLars Henning Schmidt, Janine Stucke-Ring, Caroline Brand, et al.
Plos One|August 28, 2015
PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined SubgroupsLars Henning Schmidt, Andreas Kümmel, Dennis Görlich, et al.
Plos One|June 13, 2017
Potential therapeutic impact of CD13 expression in non-small cell lung cancerLars Henning Schmidt, Caroline Brand, Janine Stucke-Ring, et al.
Plos One|August 10, 2017
Correction: Potential therapeutic impact of CD13 expression in non-small cell lung cancerLars Henning Schmidt, Caroline Brand, Janine Stucke-Ring, et al.
European Journal of Haematology|March 29, 2017
Progressive histoplasmosis with hemophagocytic lymphohistiocytosis and epithelioid cell granulomatosis: A case report and review of the literatureArik Bernard Schulze, Britta Heptner, Torsten Kessler, et al.
Plos One|October 28, 2017
Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancerLars Henning Schmidt, Birthe Heitkötter, Arik B Schulze, et al.
Translational Oncology|August 21, 2018
Aminopeptidase N (CD13): Expression, Prognostic Impact, and Use as Therapeutic Target for Tissue Factor Induced Tumor Vascular Infarction in Soft Tissue SarcomaTorsten Kessler, Ariane Baumeier, Caroline Brand, et al.
Oncotarget|October 15, 2016
Combinatorial effects of doxorubicin and retargeted tissue factor by intratumoral entrapment of doxorubicin and proapoptotic increase of tumor vascular infarctionJanine Stucke-Ring, Julian Ronnacker, Caroline Brand, et al.
Pageof 8